Recap of the Drug Discovery Seminar on Covalent Inhibitors

The second installment of our Drug Discovery Seminar Series, held on February 14th, drew a diverse audience eager to explore the cutting edge of drug development. We were privileged to host Professor Paul Brennan, Director of the Centre for Medicines Discovery at the University of Oxford, who delivered a fascinating presentation on "Discovery of covalent inhibitors of small GTPases/guanine exchange factors of the RHO-subfamily."

Professor Brennan's presentation provided a deep dive into the challenges and opportunities surrounding the development of covalent inhibitors, a class of drugs that form a strong, lasting bond with their target protein.

The seminar provided an opportunity for attendees to learn about the latest advances in drug discovery and to network with colleagues in the field. We extend our gratitude to Professor Brennan for sharing his expertise and inspiring us with his work.

Stay tuned for announcements about future seminars in our Drug Discovery Series! We look forward to welcoming you to our next event.